{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:01:41Z","timestamp":1789351301660,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Transpl Rep"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40472-015-0074-5","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T03:07:08Z","timestamp":1443582428000},"page":"316-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Antibody-Mediated Rejection in Lung Transplantation"],"prefix":"10.1007","volume":"2","author":[{"given":"H. S.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. C.","family":"Bemiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. R.","family":"Hachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"key":"74_CR1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.healun.2014.08.004","volume":"33","author":"RD Yusen","year":"2014","unstructured":"Yusen RD, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report\u20142014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33:1009\u201324.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1513\/AnnalsATS.201311-388OC","volume":"11","author":"DG Cohen","year":"2014","unstructured":"Cohen DG, Christie JD, Anderson BJ, et al. Cognitive function, mental health, and health-related quality of life after lung transplantation. Ann Am Thor Soc. 2014;11:522\u201330.","journal-title":"Ann Am Thor Soc"},{"issue":"3","key":"74_CR3","doi-asserted-by":"crossref","first-page":"02","DOI":"10.1164\/rccm.201408-1562OC","volume":"191","author":"BG Maxwell","year":"2015","unstructured":"Maxwell BG, Mooney JJ, Lee PH, et al. Increased resource use in lung transplant admissions in the lung allocation score era. Am J Respir Crit Care Med. 2015;191(3):02\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"74_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13665-012-0019-8","volume":"1","author":"R Hachem","year":"2012","unstructured":"Hachem R. Antibody-mediated lung transplant rejection. Curr Respir Care Rep. 2012;1:157\u201361.","journal-title":"Curr Respir Care Rep"},{"key":"74_CR5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/TP.0000000000000392","volume":"98","author":"GP Westall","year":"2014","unstructured":"Westall GP, Snell GI. Antibody-mediated rejection in lung transplantation. Transplantation. 2014;98:927\u201330.","journal-title":"Transplantation"},{"key":"74_CR6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","volume":"32","author":"GJ Berry","year":"2013","unstructured":"Berry GJ, Burke MM, Andersen C, et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2013;32:1147\u201362.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MOT.0000000000000079","volume":"19","author":"WD Wallace","year":"2014","unstructured":"Wallace WD, Weigt SS, Farver CF. Update on pathology of antibody-mediated rejection in the lung allograft. Curr Opin Org Transpl. 2014;19:303\u20138.","journal-title":"Curr Opin Org Transpl"},{"key":"74_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2012.11.009","volume":"28","author":"AH Daoud","year":"2013","unstructured":"Daoud AH, Betensley AD. Diagnosis and treatment of antibody mediated rejection in lung transplantation: a retrospective case series. Transpl Immunol. 2013;28:1\u20135.","journal-title":"Transpl Immunol"},{"key":"74_CR9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.healun.2012.11.018","volume":"32","author":"MM DeNicola","year":"2013","unstructured":"DeNicola MM, Weigt SS, Belperio JA, Reed EF, Ross DJ, Wallace WD. Pathologic findings in lung allografts with anti-HLA antibodies. J Heart Lung Transplant. 2013;32:326\u201332.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.healun.2013.07.004","volume":"32","author":"CA Witt","year":"2013","unstructured":"Witt CA, Gaut JP, Yusen RD, et al. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant. 2013;32:1034\u201340.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.healun.2003.08.030","volume":"23","author":"AL Girnita","year":"2004","unstructured":"Girnita AL, McCurry KR, Iacono AT, et al. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant. 2004;23:1135\u201341.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nri1702","volume":"5","author":"RB Colvin","year":"2005","unstructured":"Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol. 2005;5:807\u201317.","journal-title":"Nat Rev Immunol"},{"key":"74_CR13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.healun.2014.07.018","volume":"33","author":"MR Morrell","year":"2014","unstructured":"Morrell MR, Pilewski JM, Gries CJ, et al. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation. J Heart Lung Transplant. 2014;33:1288\u201394.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR14","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.humimm.2013.07.002","volume":"74","author":"N Angaswamy","year":"2013","unstructured":"Angaswamy N, Tiriveedhi V, Sarma NJ, et al. Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection. Hum Immunol. 2013;74:1478\u201385.","journal-title":"Hum Immunol"},{"key":"74_CR15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1378\/chest.110.5.1143","volume":"110","author":"R Shreeniwas","year":"1996","unstructured":"Shreeniwas R, Schulman LL, Narasimhan M, et al. Adhesion molecules (E-selectin and ICAM-1) in pulmonary allograft rejection. Chest. 1996;110:1143\u20139.","journal-title":"Chest"},{"key":"74_CR16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2567.1997.d01-2249.x","volume":"91","author":"AC Cunningham","year":"1997","unstructured":"Cunningham AC, Zhang JG, Moy JV, et al. A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells. Immunology. 1997;91:458\u201363.","journal-title":"Immunology"},{"key":"74_CR17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1378\/chest.120.1.225","volume":"120","author":"DS Zander","year":"2001","unstructured":"Zander DS, Baz MA, Visner GA, et al. Analysis of early deaths after isolated lung transplantation. Chest. 2001;120:225\u201332.","journal-title":"Chest"},{"key":"74_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.healun.2012.11.005","volume":"32","author":"G Berry","year":"2013","unstructured":"Berry G, Burke M, Andersen C, et al. Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant. 2013;32:14\u201321.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR19","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1016\/j.healun.2004.06.022","volume":"24","author":"D Hadjiliadis","year":"2005","unstructured":"Hadjiliadis D, Chaparro C, Reinsmoen NL, et al. Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. J Heart Lung Transplant. 2005;24:S249\u201354.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ccm.2011.02.008","volume":"32","author":"T Martinu","year":"2011","unstructured":"Martinu T, Pavlisko EN, Chen DF, Palmer SM. Acute allograft rejection: cellular and humoral processes. Clin Chest Med. 2011;32:295\u2013310.","journal-title":"Clin Chest Med"},{"key":"74_CR21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","volume":"10","author":"JM Cecka","year":"2010","unstructured":"Cecka JM. Calculated PRA, (CPRA): the new measure of sensitization for transplant candidates. Am J Transplant. 2010;10:26\u20139.","journal-title":"Am J Transplant"},{"key":"74_CR22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.tp.0000204046.89396.c5","volume":"81","author":"JZ Appel 3rd","year":"2006","unstructured":"Appel 3rd JZ, Hartwig MG, Cantu 3rd E, Palmer SM, Reinsmoen NL, Davis RD. Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies. Transplantation. 2006;81:1049\u201357.","journal-title":"Transplantation"},{"key":"74_CR23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MOT.0b013e3283636c71","volume":"18","author":"P Campbell","year":"2013","unstructured":"Campbell P. Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation. Curr Opin Organ Transpl. 2013;18:463\u20139.","journal-title":"Curr Opin Organ Transpl"},{"key":"74_CR24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1600-6143.2010.03340.x","volume":"11","author":"JM Cecka","year":"2011","unstructured":"Cecka JM, Kucheryavaya AY, Reinsmoen NL, Leffell MS. Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches. Am J Transplant. 2011;11:719\u201324.","journal-title":"Am J Transplant"},{"key":"74_CR25","unstructured":"Girnita AL, McCurry KR, Yousem SA, Pilewski J, Zeevi A. Antibody-mediated rejection in lung transplantation: case reports. Clin Transpl. 2006; 508\u201310."},{"key":"74_CR26","first-page":"415","volume":"17","author":"DB Badesch","year":"1998","unstructured":"Badesch DB, Zamora M, Fullerton D, et al. Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection. J Heart Lung Transplant. 1998;17:415\u201322.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR27","first-page":"1217","volume":"15","author":"GA Saint Martin","year":"1996","unstructured":"Saint Martin GA, Reddy VB, Garrity ER, et al. Humoral (antibody-mediated) rejection in lung transplantation. J Heart Lung Transplant. 1996;15:1217\u201322.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1034\/j.1600-6143.2003.00152.x","volume":"3","author":"CM Magro","year":"2003","unstructured":"Magro CM, Pope Harman A, Klinger D, et al. Use of C4d as a diagnostic adjunct in lung allograft biopsies. Am J Transplant. 2003;3:1143\u201354.","journal-title":"Am J Transplant"},{"key":"74_CR29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.trre.2014.03.001","volume":"28","author":"M Touzot","year":"2014","unstructured":"Touzot M, Obada EN, Beaudreuil S, Francois H, Durrbach A. Complement modulation in solid-organ transplantation. Transplant Rev. 2014;28:119\u201325.","journal-title":"Transplant Rev"},{"key":"74_CR30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.healun.2012.10.007","volume":"32","author":"LJ Lobo","year":"2013","unstructured":"Lobo LJ, Aris RM, Schmitz J, Neuringer IP. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation. J Heart Lung Transplant. 2013;32:70\u20137.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e31817cf2e2","volume":"86","author":"AL Girnita","year":"2008","unstructured":"Girnita AL, Lee TM, McCurry KR, et al. Anti-human leukocyte antigen antibodies, vascular C4d deposition and increased soluble c4d in broncho-alveolar lavage of lung allografts. Transplantation. 2008;86:342\u20137.","journal-title":"Transplantation"},{"key":"74_CR32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.healun.2007.03.007","volume":"26","author":"E Masson","year":"2007","unstructured":"Masson E, Stern M, Chabod J, et al. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies. J Heart Lung Transplant. 2007;26:642\u20135.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR33","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1600-6143.2009.02724.x","volume":"9","author":"AR Tambur","year":"2009","unstructured":"Tambur AR, Ramon DS, Kaufman DB, et al. Perception versus reality?: Virtual crossmatch\u2014how to overcome some of the technical and logistic limitations. Am J Transplant. 2009;9:1886\u201393.","journal-title":"Am J Transplant"},{"key":"74_CR34","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.healun.2015.01.038","volume":"34","author":"A Bharat","year":"2015","unstructured":"Bharat A, Steward N, DeCamp MM, et al. Autoantibodies against lung tissue can cause hyper acute as well as acute antibody mediated rejection following lung transplantation. J Heart Lung Transplant. 2015;34:S19. Abstract.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR35","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1164\/rccm.201312-2160OC","volume":"189","author":"M Kim","year":"2014","unstructured":"Kim M, Townsend KR, Wood IG, et al. Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates. Am J Respir Crit Care Med. 2014;189:1234\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"74_CR36","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1046\/j.1600-6143.2003.00229.x","volume":"3","author":"CM Magro","year":"2003","unstructured":"Magro CM, Klinger DM, Adams PW, et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant. 2003;3:1264\u201372.","journal-title":"Am J Transplant"},{"key":"74_CR37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trim.2014.06.004","volume":"31","author":"S Otani","year":"2014","unstructured":"Otani S, Davis AK, Cantwell L, et al. Evolving experience of treating antibody-mediated rejection following lung transplantation. Transpl Immunol. 2014;31:75\u201380.","journal-title":"Transpl Immunol"},{"key":"74_CR38","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/j.1600-6143.2012.04172.x","volume":"12","author":"EC Jolly","year":"2012","unstructured":"Jolly EC, Key T, Rasheed H, et al. Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation. Am J Transplant. 2012;12:2845\u20138.","journal-title":"Am J Transplant"},{"key":"74_CR39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.healun.2003.08.028","volume":"23","author":"ML Rose","year":"2004","unstructured":"Rose ML. De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system. J Heart Lung Transplant. 2004;23:385\u201395.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR40","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.athoracsur.2010.06.009","volume":"90","author":"A Bharat","year":"2010","unstructured":"Bharat A, Saini D, Steward N, et al. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thor Surg. 2010;90:1094\u2013101.","journal-title":"Ann Thor Surg"},{"key":"74_CR41","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.healun.2014.01.253","volume":"33","author":"A Bharat","year":"2014","unstructured":"Bharat A, Subramaniam V, Kreisel D, Decamp M, Mohanakumar T. Novel two-hit hypothesis for the development of de novo autoimmunity following lung transplantation. J Heart Lung Transplant. 2014;33:S81.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR42","unstructured":"Zeevi A, Marrari M, Lunz J, et al. The big picture: a case report of antibody mediated rejection and treatment after lung transplantation illustrating the need to correlate laboratory findings with clinical status. Clin Transpl. 2013; 399\u2013405."},{"key":"74_CR43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.trim.2012.08.002","volume":"27","author":"D Hayes Jr","year":"2012","unstructured":"Hayes Jr D, DiPaola N, Baker PB, Kirkby S, Phillips AB, Nicol KK. Antibody-mediated rejection in a lung transplant recipient after acute stroke. Transpl Immunol. 2012;27:171\u20134.","journal-title":"Transpl Immunol"},{"key":"74_CR44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.healun.2008.09.013","volume":"28","author":"MR Morrell","year":"2009","unstructured":"Morrell MR, Patterson GA, Trulock EP, Hachem RR. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant. 2009;28:96\u2013100.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR45","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1600-6143.2004.00500.x","volume":"4","author":"SK Takemoto","year":"2004","unstructured":"Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004;4:1033\u201341.","journal-title":"Am J Transplant"},{"key":"74_CR46","unstructured":"Girnita AL, McCurry KR, Zeevi A. Increased lung allograft failure in patients with HLA-specific antibody. Clin Transpl. 2007; 231\u20139."},{"key":"74_CR47","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00007890-199911270-00018","volume":"68","author":"JC Scornik","year":"1999","unstructured":"Scornik JC, Zander DS, Baz MA, Donnelly WH, Staples ED. Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry. Transplantation. 1999;68:1542\u20136.","journal-title":"Transplantation"},{"key":"74_CR48","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1164\/ajrccm.160.3.9706115","volume":"160","author":"JK Choi","year":"1999","unstructured":"Choi JK, Kearns J, Palevsky HI, et al. Hyperacute rejection of a pulmonary allograft. Immediate clinical and pathologic findings. Am J Respir Crit Care Med. 1999;160:1015\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"74_CR49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ejcts\/ezs066","volume":"42","author":"JL Campo-Canaveral de la Cruz","year":"2012","unstructured":"Campo-Canaveral de la Cruz JL, Naranjo JM, Salas C, Varela de Ugarte A. Fulminant hyperacute rejection after unilateral lung transplantation. Eur J Cardiothor Surg. 2012;42:373\u20135.","journal-title":"Eur J Cardiothor Surg"},{"key":"74_CR50","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.athoracsur.2012.09.089","volume":"95","author":"CA Beaty","year":"2013","unstructured":"Beaty CA, Yang A, George TJ, Illei PB, Shah AS. Unilateral humoral rejection after reoperative single-lung transplant. Ann Thorac Surg. 2013;95:e79\u201381.","journal-title":"Ann Thorac Surg"},{"key":"74_CR51","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1111\/tri.12224","volume":"27","author":"F Chen","year":"2014","unstructured":"Chen F, Miyagawa-Hayashino A, Yurugi K, et al. Redo living-donor lobar lung transplantation for bronchiolitis obliterans associated with antibody-mediated rejection. Transpl Int. 2014;27:e8\u201312.","journal-title":"Transpl Int"},{"key":"74_CR52","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.healun.2012.09.016","volume":"31","author":"KL Dawson","year":"2012","unstructured":"Dawson KL, Parulekar A, Seethamraju H. Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab. J Heart Lung Transplant. 2012;31:1325\u20136.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR53","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","volume":"26","author":"S Stewart","year":"2007","unstructured":"Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26:1229\u201342.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR54","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","volume":"14","author":"M Haas","year":"2014","unstructured":"Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14:272\u201383.","journal-title":"Am J Transplant"},{"key":"74_CR55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-62703-493-7_7","volume":"1034","author":"JK Patel","year":"2013","unstructured":"Patel JK, Kobashigawa JA. Thoracic organ transplantation: laboratory methods. Methods Mol Biol. 2013;1034:127\u201343.","journal-title":"Methods Mol Biol"},{"key":"74_CR56","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.healun.2010.05.006","volume":"29","author":"RR Hachem","year":"2010","unstructured":"Hachem RR, Yusen RD, Meyers BF, et al. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant. 2010;29:973\u201380.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","volume":"32","author":"A Zeevi","year":"2013","unstructured":"Zeevi A, Lunz J, Feingold B, et al. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant. 2013;32:98\u2013105.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR58","doi-asserted-by":"crossref","unstructured":"Tambur AR, Herrera ND, Haarberg KM, et al. Assessing antibody strength: comparison of MFI, C1q, and titer information. Am J Transpl. 2015.","DOI":"10.1111\/ajt.13295"},{"key":"74_CR59","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1016\/j.healun.2012.01.519","volume":"31","author":"HW Ainge Allen","year":"2012","unstructured":"Ainge Allen HW, Havryk AP, Malouf MA, et al. IgM depletion discovers undetected donor specific antibodies associated with antibody mediated rejection after lung transplantation [abstract]. J Heart Lung Transplant. 2012;31:S177.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR60","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2012.04079.x","volume":"12","author":"RR Hachem","year":"2012","unstructured":"Hachem RR, Tiriveedhi V, Patterson GA, Aloush A, Trulock EP, Mohanakumar T. Antibodies to K-alpha 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant. 2012;12:2164\u201371.","journal-title":"Am J Transplant"},{"key":"74_CR61","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ki.2011.497","volume":"81","author":"D Cohen","year":"2012","unstructured":"Cohen D, Colvin RB, Daha MR, et al. Pros and cons for C4d as a biomarker. Kidney Int. 2012;81:628\u201339.","journal-title":"Kidney Int"},{"key":"74_CR62","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.healun.2008.03.018","volume":"27","author":"GP Westall","year":"2008","unstructured":"Westall GP, Snell GI, McLean C, Kotsimbos T, Williams T, Magro C. C3d and C4d deposition early after lung transplantation. J Heart Lung Transplant. 2008;27:722\u20138.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.trim.2005.05.001","volume":"15","author":"DN Ionescu","year":"2005","unstructured":"Ionescu DN, Girnita AL, Zeevi A, et al. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transplant Immunol. 2005;15:63\u20138.","journal-title":"Transplant Immunol"},{"key":"74_CR64","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.healun.2014.06.006","volume":"33","author":"AC Roden","year":"2014","unstructured":"Roden AC, Maleszewski JJ, Yi ES, et al. Reproducibility of complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies. J Heart Lung Transplant. 2014;33:1223\u201332.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR65","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335:2\u201313.","journal-title":"Mol Cell Endocrinol"},{"key":"74_CR66","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.healun.2012.01.204","volume":"31","author":"S Chih","year":"2012","unstructured":"Chih S, Tinckam K, Ross HJ. A survey of current practice for antibody mediated rejection in heart transplantation to guide treatment standardization. J Heart Lung Transplant. 2012;31:S77. abstract.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR67","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.healun.2005.05.015","volume":"24","author":"TL Astor","year":"2005","unstructured":"Astor TL, Weill D, Cool C, Teitelbaum I, Schwarz MI, Zamora MR. Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. J Heart Lung Transpl. 2005;24:2091\u20137.","journal-title":"J Heart Lung Transpl"},{"key":"74_CR68","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","volume":"29","author":"MR Costanzo","year":"2010","unstructured":"Costanzo MR, Dipchand A, Starling R, et al. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914\u201356.","journal-title":"J Heart Lung Transplant"},{"key":"74_CR69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","volume":"28","author":"J Schwartz","year":"2013","unstructured":"Schwartz J, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013;28:145\u2013284.","journal-title":"J Clin Apher"},{"key":"74_CR70","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jca.21270","volume":"28","author":"R Jackups","year":"2013","unstructured":"Jackups R, Canter C, Sweet SC, Mohanakumar T, Morris GP. Measurement of donor-specific hla antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection. J Clin Apher. 2013;28:301\u20138.","journal-title":"J Clin Apher"},{"key":"74_CR71","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/00007890-200211150-00013","volume":"74","author":"CM Magro","year":"2002","unstructured":"Magro CM, Deng A, Pope-Harman A, et al. Humorally mediated posttransoplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation. 2002;74:1273\u201380.","journal-title":"Transplantation"},{"key":"74_CR72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-6143.2010.03400.x","volume":"11","author":"SC Jordan","year":"2011","unstructured":"Jordan SC, Toyoda M, Kahwaji J, Vo AA. Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients. Am J Transplant. 2011;11:196\u2013202.","journal-title":"Am J Transplant"},{"key":"74_CR73","doi-asserted-by":"crossref","first-page":"1018A","DOI":"10.1378\/chest.1704606","volume":"144","author":"K Townsend","year":"2013","unstructured":"Townsend K, Kim M, Wood I, et al. Combination therapy with plasmapheresis, IVIg, and rituximab provides benefit in the management of early antibody mediated rejection in lung transplant in a pilot cohort. Chest. 2013;144:1018A. Abstract.","journal-title":"Chest"},{"key":"74_CR74","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4161\/mabs.26008","volume":"5","author":"J Golay","year":"2013","unstructured":"Golay J, Semenzato G, Rambaldi A, et al. Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics. mAbs. 2013;5:826\u201337.","journal-title":"mAbs"},{"key":"74_CR75","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/TP.0b013e3181fdd9b0","volume":"90","author":"SM Flechner","year":"2010","unstructured":"Flechner SM, Fatica R, Askar M, et al. The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation. Transplantation. 2010;90:1486\u201392.","journal-title":"Transplantation"},{"key":"74_CR76","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.healun.2013.08.017","volume":"32","author":"C Baum","year":"2013","unstructured":"Baum C, Reichenspurner H, Deuse T. Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation. J Heart Lung Transplant. 2013;32:1270\u20131.","journal-title":"J Heart Lung Transplant"}],"container-title":["Current Transplantation Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40472-015-0074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40472-015-0074-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40472-015-0074-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T03:35:53Z","timestamp":1567222553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40472-015-0074-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["74"],"URL":"https:\/\/doi.org\/10.1007\/s40472-015-0074-5","relation":{},"ISSN":["2196-3029"],"issn-type":[{"value":"2196-3029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,30]]}}}